Valuation: Labcorp Holdings Inc.

Market Cap 26.68B 23.86B 22.07B 19.98B 37.4B 2,538B 38.01B 266B 105B 1,328B 100B 97.99B 4,203B P/E 2026 *
23x
P/E 2027 * 20.9x
Enterprise Value 31.83B 28.46B 26.33B 23.84B 44.62B 3,028B 45.35B 317B 125B 1,584B 119B 117B 5,015B EV / Sales 2026 *
2.16x
EV / Sales 2027 * 2.02x
Free-Float
99.65%
Yield 2026 *
0.89%
Yield 2027 * 0.9%
1 day+0.29%
1 week+3.47%
Current month+7.07%
1 month+6.57%
3 months+9.54%
6 months+25.23%
Current year+31.50%
1 week 314.78
Extreme 314.78
331.76
1 month 302.71
Extreme 302.71
331.76
Current year 245
Extreme 245
341.8
1 year 244.52
Extreme 244.52
341.8
3 years 191.97
Extreme 191.97
341.8
5 years 191.97
Extreme 191.97
341.8
10 years 98.02
Extreme 98.02
341.8
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Chief Technology Officer

3,000 0.0037%
01/09/26 Free

Chief Technology Officer

750 0.0009%
01/09/26 Free

EVP, COO

900 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+0.29%+3.47%+19.68%+60.21% 26.68B
-1.01%-0.16%+12.23%+36.11% 120B
-0.80%+2.28%-0.56%+109.76% 102B
+0.24%+1.37%+110.64%+936.88% 58.23B
+0.61%+2.27%-5.92%+84.55% 29.08B
+0.44%+3.42%+34.78%+85.09% 26.61B
+0.19%+0.96%+24.42%+403.56% 21.62B
+5.16%+0.90%-18.01%-3.45% 19.86B
-19.92%-19.22%-17.70%+52.99% 18.93B
-0.76%-2.00%-5.88%+31.54% 17.09B
Average -1.56%+1.30%+15.37%+179.72% 43.92B
Weighted average by Cap. -0.99%+1.67%+20.18%+197.05%

Financials

2026 *2027 *
Net sales 14.75B 13.19B 12.2B 11.05B 20.68B 1,403B 21.02B 147B 58.08B 734B 55.36B 54.17B 2,324B 15.47B 13.83B 12.79B 11.58B 21.68B 1,471B 22.04B 154B 60.9B 770B 58.04B 56.8B 2,437B
Net income 1.13B 1.01B 935M 847M 1.58B 108B 1.61B 11.25B 4.45B 56.26B 4.24B 4.15B 178B 1.24B 1.11B 1.03B 930M 1.74B 118B 1.77B 12.37B 4.89B 61.81B 4.66B 4.56B 196B
Net Debt 5.15B 4.61B 4.26B 3.86B 7.22B 490B 7.34B 51.27B 20.28B 256B 19.33B 18.92B 812B 4.51B 4.03B 3.73B 3.38B 6.32B 429B 6.42B 44.89B 17.76B 224B 16.92B 16.56B 710B
Projected Income Statement - Annual - Labcorp Holdings Inc.
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
-
Date Price Change Volume
26/10/26 US$329.90 +0.29% 653,702
23/10/26 US$328.95 -0.30% 663,981
22/10/26 US$329.93 +1.91% 961,977
21/10/26 US$323.75 +0.19% 566,728
20/10/26 US$323.13 +1.35% 591,765
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Labcorp Holdings Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
328.95USD
Average target price
345.12USD
Spread / Average Target
+4.92%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Labcorp Holdings Inc.